RedHill Biopharma Ltd. to Present at the JMP Securities Annual Healthcare Conference in New York
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TEL-AVIV, Israel, July 3, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, patent-protected, new formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the 8th Annual JMP Securities Healthcare Conference to be held on Wednesday, July 10, 2013 at 12:00 p.m. EDT at The St. Regis Hotel in New York City. A copy of the presentation to be made by the Company has been uploaded to the Company's website and may be viewed at the following web address: http://ir.redhillbio.com/events.cfm.
Help employers find you! Check out all the jobs and post your resume.
TEL-AVIV, Israel, July 3, 2013 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, patent-protected, new formulations and combinations of existing drugs, today announced that Dror Ben-Asher, the Company's Chief Executive Officer, will present an overview of the Company at the 8th Annual JMP Securities Healthcare Conference to be held on Wednesday, July 10, 2013 at 12:00 p.m. EDT at The St. Regis Hotel in New York City. A copy of the presentation to be made by the Company has been uploaded to the Company's website and may be viewed at the following web address: http://ir.redhillbio.com/events.cfm.
Help employers find you! Check out all the jobs and post your resume.